Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Share ownership Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 21:00:02 13/09/2024 BST 		5-day change 1st Jan Change
923.71 USD -1.21% Intraday chart for Eli Lilly and Company +2.33% +58.46%
09-13 Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss DJ
09-13 Eli Lilly Gets US FDA Approval for Atopic Dermatitis Treatment MT

Share class: Eli Lilly and Company

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1950,790,778948,974,230 ( 99.81 %) 365,000 ( 0.0384 %) 99.81 %

Major shareholders: Eli Lilly and Company

NameEquities%Valuation
Lilly Endowment, Inc.
10.19 %
96,891,978 10.19 % 93 018 M $
Vanguard Fiduciary Trust Co.
7.771 %
73,859,008 7.771 % 70 906 M $
PNC Investments LLC
5.409 %
51,404,836 5.409 % 49 350 M $
BlackRock Advisors LLC
5.338 %
50,737,543 5.338 % 48 709 M $
State Street Corp.
3.564 %
33,877,562 3.564 % 32 523 M $
Fidelity Management & Research Co. LLC
3.522 %
33,472,923 3.522 % 32 135 M $
Capital Research & Management Co. (World Investors)
2.295 %
21,813,763 2.295 % 20 942 M $
T. Rowe Price International Ltd.
2.173 %
20,651,736 2.173 % 19 826 M $
PRIMECAP Management Co.
2.064 %
19,618,082 2.064 % 18 834 M $
JPMorgan Investment Management, Inc.
1.951 %
18,544,780 1.951 % 17 803 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Caixa DTVM SA
0.001481 %
422,740 0.001481 % 13 M $
Western Asset Management Company DTVM Ltda.
0.000686 %
195,773 0.000686 % 6 M $
Bram Bradesco Asset Management S/A DTVM
0.000177 %
50,610 0.000177 % 2 M $
Safra Asset Management Ltda.
0.000105 %
30,000 0.000105 % 949 270 $
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000034 %
9,625 0.000034 % 304 557 $
XP Allocation Asset Management Ltda.
0.000015 %
4,347 0.000015 % 137 549 $
Santander Brasil Gestão de Recursos Ltda.
0.000005 %
1,390 0.000005 % 43 983 $
BB Gestão de Recursos DTVM SA
0.000004 %
1,000 0.000004 % 31 642 $

Breakdown by shareholder type

Institutional69.69%
Other8.07%
State Street Corp.3.56%
Schweizerische Nationalbank0.25%
Sumitomo Mitsui Trust Holdings, Inc.0.20%
Manulife Financial Corp.0.16%
Individuals0.14%
Swedbank AB0.13%
Governments0.12%
SEI Investments Co.0.06%
Fifth Third Bancorp0.05%
Regions Financial Corp.0.04%
Skandinaviska Enskilda Banken AB0.04%
Zurich Insurance Group AG0.03%
The Bank of Nova Scotia0.03%
Corebridge Financial, Inc.0.02%
Peapack-Gladstone Financial Corp.0.01%
Clal Insurance Enterprises Holdings Ltd.0.01%
ING Groep NV0.01%
Polar Capital Holdings Plc0.01%
Cullen/Frost Bankers, Inc.0.01%
Rathbones Group Plc0.01%
Unknown17.35%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 67.61%
United Kingdom 7.91%
Norway 1.26%
Canada 1.09%
France 0.79%
Sweden 0.58%
Switzerland 0.57%
Japan 0.49%
Australia 0.47%
Germany 0.39%
Netherlands 0.24%
South Korea 0.21%
Denmark 0.16%
Individuals 0.14%
Luxembourg 0.14%
Belgium 0.12%
Ireland 0.11%
Italy 0.08%
Finland 0.05%
Cayman Islands 0.04%
Spain 0.04%
New Zealand 0.03%
Austria 0.03%
Singapore 0.03%
Czech Republic 0.02%
Israel 0.02%
Hong Kong 0.01%
Slovenia 0.01%
South Africa 0.01%
Taiwan 0.01%

Based on 1000 largest holdings

Company Profile

Logo Eli Lilly and Company
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Employees
43,000
Sector
Pharmaceuticals
Calendar
30/10/2024 - Q3 2024 Earnings Release
More about the company
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Company Eli Lilly and Company
  5. Share ownership
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition